Constellation Software shares fell on Monday, November 9, in the first Trading session after the company released third-quarter results late on Friday. Revenue grew strongly, but almost all of that growth came from acquisitions. Organic growth stayed thin and free Cash Flow fell, and investors marked the stock down while the wider market rallied.

What happened

Constellation Software (TSX:CSU) closed at C$3,392.29, down C$134.23 from Friday's close of C$3,526.52. That was one of the steepest declines on the S&P/TSX Composite, which jumped about 657 points to 36,446.26.

The company reported after the bell on Friday, November 6. Revenue for the quarter ended September 30 rose to US$3.51 billion from US$2.95 billion a year earlier, a gain of US$564 million.

The catch was where that growth came from. Organic growth was only in the low single digits, both before and after currency effects. The rest came from businesses Constellation bought.

Free cash flow available to shareholders, the measure the company watches most closely, fell to US$443 million from US$529 million. Management linked much of that to a non-cash charge of US$117 million tied to the Revaluation of a minority interest in Topicus.

Net income attributable to shareholders edged up to US$212 million, or US$10.01 a diluted share, from US$210 million. The board kept the quarterly Dividend at US$1.00 a share.

The timing points to the results as the most likely reason for the drop.

Why it matters

Constellation's model is simple: buy small, sticky vertical-market software firms and hold them for good. Investors have long paid a premium for the steady compounding that produces.

That premium depends on the acquired businesses growing on their own, not just getting bigger through deals. On the call, president Mark Miller pointed investors to recurring revenue: "The measure we actually care a lot about is watching maintenance and other recurring revenue."

That line grew organically at a mid-single-digit pace. But a US healthcare segment shrank in the quarter, which management tied largely to recently acquired businesses that were already in decline.

The bigger picture

The other open question is artificial intelligence. Software stocks have been hit repeatedly this year by fears that AI tools could erode Demand for traditional applications.

Management said experimentation with AI is widespread across its more than 1,600 businesses, but spending is not yet material to results. Miller described the company as "experimenting hard, running quickly, and still early."

Bernie Blais, who leads mergers and acquisitions, said he did not see sellers rushing for the exit: "I don't know that there's a massive trend for everyone throwing in the towel in the software business."

The company also continued to deploy capital. It spent US$484 million in cash on acquisitions in the quarter, with an estimated US$125 million more in deferred payments.

As usual, Constellation gave no numerical guidance, which leaves investors to judge the outlook from each quarter's numbers.

What to watch next

Analysts will likely revisit their models and price targets in the coming days after the weak organic figure. Any shift in their views could move the stock further.

Longer term, watch whether organic growth in maintenance and Recurring Revenue holds up, and whether the US healthcare drag fades. Investors will also want signs that the company's AI work turns into new revenue rather than just defending what it has.

The pace of acquisitions matters too. Constellation's long-term returns rest on finding enough good deals at sensible prices.